An x-ray fluorescence (XRF) system designed for monitoring of skin Fe concentrations has been performance tested for use on patients treated for beta-thalassaemia. The essentials of the system are: a collimated x-ray tube operated at 20 kV and 20 mA; energy selection of the x-ray beam by means of a Cu K-edge filter; use of skin phantoms containing concentrations of Fe in the range 10 to 100 parts per million (ppm); and a high-purity germanium detector placed at 90 degrees to the incident beam. For a Cu K-edge filter of 0.15 mm thickness a quasi-monoenergetic beam of approximately 8.4 keV is obtained which is close to the absorption edge of Fe (7.11 keV). For a real-time counting period of 400s the systemis capable of detecting Fe concentrations of 15+/-2 ppm at a skin dose of the order of 5 mSv. This level of Fe is at the higher end of the normal range found in the skin. In using the same system and operating parameters, measurements on a sample of ferritin obtained from a rat's liver yield an Fe concentration of 36+/-3 ppm for a measurement time of 500 s; this can be compared with suppliers' data indicating an Fe level of 36 ppm.
No takes yet. Share an insight, caveat, or question.
Farquharson et al. (1999) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: